Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-25-085820

Chief Operating Officer sold 207,000 shares at $0.01 ($2,091)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bertrand William C JR Chief Operating Officer 2025-08-28 Sale −207,000 $0.01 $2,091 986,352 D
Open-market sales · 207,000 sh · avg $0.01 · $2,091
Loading xslF345X05/tm2524763-1_4seq1.xml…